Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (691-700 of 850) with videos related to

Pageof 85
Sort By:
European Urology|July 13, 2014
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancerStefan Steurer, Pascale Sophia Mayer, Meike Adam, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
The Journal of Sexual Medicine|May 27, 2017
External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate CancerRaisa S Pompe, Pierre I Karakiewicz, Emanuele Zaffuto, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
Scientific Reports|August 9, 2022
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoproteinSergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
Journal of Robotic Surgery|July 5, 2025
Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
Cancers|August 10, 2024
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History PatientsFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
Pageof 85

Showing results (691-700 of 850) with videos related to

Sort By:
Pageof 85
European Urology|July 13, 2014
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancerStefan Steurer, Pascale Sophia Mayer, Meike Adam, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
The Journal of Sexual Medicine|May 27, 2017
External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate CancerRaisa S Pompe, Pierre I Karakiewicz, Emanuele Zaffuto, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
Scientific Reports|August 9, 2022
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoproteinSergey A Dyshlovoy, Larisa K Shubina, Tatyana N Makarieva, et al.
Journal of Robotic Surgery|July 5, 2025
Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
Cancers|August 10, 2024
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History PatientsFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
Pageof 85